When compared with atorvastatin users, those taking rosuvastatin had an 8% higher chance of getting blood in their urine, a ...

ORLANDO, Florida (Reuters) - Pfizer Inc's Lipitor and AstraZeneca's Crestor cholesterol drugs, taken at their highest dose, safely reduced artery-clogging plaque in heart patients, according to data ...

The metabolic syndrome is increasingly found in a substantial and rising proportion of the US population and is associated with increased risk of cardiovascular disease events (acute coronary ...

With the government's blessing, a drug giant is about to expand the market for its blockbuster cholesterol medication Crestor to a new category of customers: as a preventive measure for millions of ...

This article was originally on a blog post platform and may be missing photos, graphics or links. See About archive blog posts. A Food and Drug Administration advisory panel recommended today that ...

It works by decreasing the production of cholesterol in the body that may build up on the artery walls. Too much cholesterol on artery walls can cause blockages of blood flow to the heart, brain, and ...

With the government's blessing, a drug giant is about to expand the market for its blockbuster cholesterol medication Crestor to a new category of customers: as a preventive measure for millions of ...

Use of OTC dietary supplements is increasingly common, sometimes replacing guideline-recommended therapies. Rosuvastatin was associated with larger reductions in LDL-C compared with placebo, fish oil, ...

Few real-world studies have investigated the risks of hematuria and proteinuria associated with rosuvastatin use. Rosuvastatin may increase the risk of hematuria, proteinuria, and kidney failure, ...

Crestor is approved for use in adults and children who are at least 8 years old. While there are other medications on the market that are used to treat these conditions, there is not currently a drug ...

Idea Evolver is the only provider to successfully complete Actual Use Trial for FDA review for Rx-to-OTC Switch Approval Fady Boctor, Petros' President and Chief Commercial Officer, commented, "This ...